SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Immuron Says Travelan Phase 2 Trial Results Published in Scientific Reports

Immuron said data from its Phase 2 clinical trial of once-daily oral Travelan were published in the journal Scientific Reports.

IMC